[Skip to Navigation]
[Skip to Navigation Landing]
April 1995

Reduced Inhibitory Capacity in Prefrontal Cortex of Schizophrenics

Author Affiliations

Interdepartmental Program for Neuroscience University of California, Los Angeles Los Angeles, CA 90095
Los Angeles Correspondence to Life Sciences Building, University of California, Los Angeles, Los Angeles, CA 90024-1606 (Dr Tobin).

Arch Gen Psychiatry. 1995;52(4):267-268. doi:10.1001/archpsyc.1995.03950160017003

Understanding the neural substrates of schizophrenia has long been a goal of psychiatrists and neurobiologists. For the clinician, more precise understanding could translate into advances in diagnosis and treatment. For the neurobiologist, such knowledge could provide general insights into the mechanisms of higher cognitive function.

Much recent work has focused on the prefrontal cortex (PFC), especially the dorsolateral PFC (DLPFC), which roughly corresponds to Brodmann's area 9. While changes in other brain regions have been reported,1,2 a growing body of converging evidence suggests that disruptions of the DLPFC play a particularly important role in the origins and course of the illness. Positron emission tomography studies,3 regional cerebral blood flow studies in patients performing the Wisconsin Card Sort,4 and cytoarchitectonic studies1 have revealed abnormalities in the DLPFC. These studies suggest that in schizophrenics, the DLPFC is hypoactive relative to other brain regions.